Antibodies against fibroblast growth factor 23
Abstract
A objective of the present invention provides anti-fibroblast Growth factor-23 antibody. Namely, wherein the control phosphate or metabolism the group comprising metabolism an antibody, and (a), (b), (c) antibody, wherein the antibody comprising the polypeptide of amino acid sequence by use of one of shown in SEQ ID NO: 1 or comprising one or more from the amino acid sequence of SEQ ID NO: 1 as a deletion, wherein the or incremental an amino acid sequence of amino acid and at most obtained, and a fibre growth factor 23 active polypeptide immune animals to obtain. the (a) a recognition to SEQ ID NO: 1 in the amino acid sequence in a 180th to 194th or 237th amino acid sequence of said 251st. the (b) a collection number of FERM BP-7838 FERM, BP-7839, FERM, BP-7840 antibody or BP-8268 FERM hybridoma producing. the (c) one of the collection number of FERM BP-7838 FERM, BP-7839, FERM, BP-7840 one of competition antibody or BP-8268 FERM hybridoma producing.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
21 members in 12 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 2001401689 | Japan | A | |
| 2002262020 | Japan | A | |
| 0300017 | Japan | W |
Members21
| Document | Office | Kind | |
|---|---|---|---|
| CA2471656A1 | Canada | A1 | |
| WO03057733A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003202472A1 | Australia | A1 | |
| KR20040073518A | Republic of Korea | A | |
| EP1466925A1 | European Patent Office (EPO) | A1 | |
| US2005048058A1 | United States of America | A1 | |
| JPWO2003057733A1 | Japan | A1 | |
| CN1639193A | China | A | |
| EP1466925A4 | European Patent Office (EPO) | A4 | |
| HK1078093A | Hong Kong, China | A | |
| CN100519584C | China | C | |
| EP1466925B1 | European Patent Office (EPO) | B1 | |
| AT441666TThis record | Austria | T | |
| ATE441666T1 | Austria | T1 | |
| DE60329070D1 | Germany | D1 | |
| AU2003202472B2 | Australia | B2 | |
| ES2331414T3 | Spain | T3 | |
| JP4527982B2 | Japan | B2 | |
| KR101016476B1 | Republic of Korea | B1 | |
| US7923012B2 | United States of America | B2 | |
| CA2471656C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 3701009
Titles2
- German
- ANTIKÍRPER GEGEN DEN FIBROBLASTENWACHSTUMSFAKTOR 23
- English
- ANTI-CRISP AGAINST THE FIBROBLAST GROWTH FACTOR 23
Classification
- CPC, 19
- C07K14/50
- A61K39/00
- A61K2039/505
- A61P3/00
- C07K16/22
- A61P3/12
- A61P3/14
- A61P5/06
- A61P5/18
- A61P5/20
- A61P7/08
- A61P13/00
- A61P13/12
- A61P17/04
- A61P19/00
- A61P19/08
- A61P19/10
- A61P21/00
- A61P35/00
- IPC, 9
- A61K39 00
- A61K39 395
- A61P13 12
- A61P19 08
- A61P19 10
- A61P3 12
- C07K14 50
- C07K16 22
- C12P21 08